Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Regulatory and Compliance Packaging/Labeling Services

Active

Federal

Response Deadline08/10/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract requires the provision of military-compliant packaging, labeling, and barcoding services specifically for pharmaceutical products, adhering strictly to Defense Logistics Agency standards and Military Standards for documentation and identification. All work must meet the rigorous regulatory and compliance requirements set by the Department of Defense to ensure uniformity, traceability, and readiness across military medical supply chains. The effort is classified as a subcontract under NAICS code 325991, indicating it involves other pharmaceutical and medicinal product manufacturing activities outside of bulk drug production. The solicitation was posted on August 2, 2026, with a firm response deadline of August 10, 2026, and the contracting office is under the Medical Supply Chain Pharm FSA within the Department of Defense. While specific performance locations and point of contact details are not provided, the services are intended to support military medical logistics operations globally. Compliance with MIL-STD specifications for packaging integrity, label content, and barcode formatting is mandatory, and successful bidders must demonstrate capability to consistently meet these standards under federal oversight.

General Info

Military-compliant pharmaceutical packaging, labeling, and barcoding per DoD standards for global medical supply chains.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325991 - Custom Compounding of Purchased ResinsView NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 2

subcontract

Response DeadlineAug 10

Submission deadline

Response Deadline

08/10/2026, 05:00:00 PM UTCin 7 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Provide military-compliant packaging, labeling, and barcoding services for pharmaceuticals per DLA and MIL-STD requirements.

Similar Contracts

Same NAICS industry code

Medical Packaging and DLA Supply Chain ComplianceThe contract requires strict adherence to DLA packaging standards for medical supplies, ensuring sterility is preserved throughout the supply chain, environmental conditions are properly controlled, and packaging withstands the stresses of transport and handling. This includes the potential for kitting or repackaging medical items to meet operational requirements, with all activities designed to maintain the integrity and readiness of critical healthcare materials. Compliance is non-negotiable, and all packaging methods must align with established military and medical logistics protocols. The contract is classified as a subcontract with a NAICS code of 325991, issued under the Department of Defense’s Medical Supply Chain FSH office. Bidders must submit proposals by August 10, 2026, with the solicitation posted on August 2, 2026. The place of performance and point of contact details are not specified, but performance is expected to support federal medical supply chain operations. The contract can be accessed through the DIBBS portal using the provided reference link.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Pharmaceutical Packaging & Unit Dose RepackagingThe contract entails the unit dose repackaging of Diazepam tablets for military use, following strict standards including DLA RP001, ASTM D3951, and MIL-STD-129, ensuring compliance with military packaging and labeling requirements. The work includes serialization and barcoding of each unit dose to support traceability and inventory management, alongside proper preservation techniques to maintain drug integrity during storage and transit. All packaging must meet the durability and environmental protection criteria necessary for military logistics operations. Performance is required at the specified location in San Diego, California, with a response deadline of August 10, 2026, and the solicitation was posted on August 2, 2026. The contract is categorized as a subcontract under NAICS code 325991, which pertains to other pharmaceutical and medicinal product manufacturing. The overseeing agency is the Department of Defense through the Medical Supply Chain Pharm FSA, and the work supports the broader military pharmaceutical distribution network, requiring full adherence to federal and defense-specific regulations throughout the repackaging process.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Packaging & Labeling ServicesThe contract requires the provision of military-compliant packaging and labeling services for Tramadol Hydrochloride Tablets, ensuring full adherence to Defense Logistics Agency standards. This includes the application of barcoding, preservation techniques, and precise marking with mandatory identifiers such as NSN, TCN, RDD, and contract-specific codes to support accurate inventory management and distribution within the Department of Defense supply chain. The work must meet all regulatory and operational requirements for pharmaceuticals destined for military use, with strict attention to durability, legibility, and compliance with federal specifications. This is a subcontract under the Defense Logistics Agency, categorized under NAICS code 325991 for other pharmaceutical and medicinal product manufacturing. The contract was posted on August 2, 2026, and is associated with the award reference SPE2DX25D8022 and delivery order SPE2D926F7845. Performance may occur at any location as determined by the contractor’s operational needs, with no specific place of performance designated. The contract does not indicate a set-aside type or point of contact, and all activities must align with DLA’s procedural and logistical guidelines for defense pharmaceuticals.

Defense Logistics Agency

POSTED

DEADLINE

Sterile Medical Device Packaging and LabelingThe contract entails the final packaging, labeling, and kitting of cautery devices to meet strict federal and military medical marking standards, requiring precise adherence to shelf-life coding, hazard communication labels, and Government identification marking protocols. All work must ensure full compliance with regulatory requirements for sterile medical devices destined for military use, with particular attention to accuracy and traceability in label content and packaging integrity. The performance location is designated as Fort Hood, Texas, with the work being executed under a subcontract arrangement through the Department of Defense’s Medical Supply Chain. The solicitation, issued under NAICS code 325991 for other miscellaneous pharmaceutical and medical product manufacturing, was posted on August 2, 2026, with a response deadline of August 10, 2026. While no set-aside type is specified, the procurement is managed by the MEDICAL SUPPLY CHAIN MD SURG FSF office and is accessible through the DIBBS platform. Contractors must be prepared to meet all defense-specific labeling and packaging mandates, ensuring products are ready for direct deployment in military medical environments without further modification or reprocessing.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Product Packaging and Labeling ServicesThe contract mandates the packaging, labeling, and kitting of medical supplies in strict compliance with MIL-STD-129, DLA RP001, and hazardous materials regulations, ensuring all procedures meet federal defense and safety standards. Services must be performed with precision to support the U.S. Department of Defense’s Medical Supply Chain Pharm FSA, with performance centered at the FPO location identified by zip code 96691. The work falls under NAICS code 325991 for other chemical product and preparation manufacturing, indicating the specialized nature of the medical packaging operations involved. This is a subcontract opportunity with a response deadline of August 10, 2026, and was posted on August 2, 2026, allowing vendors sufficient time to prepare and submit proposals. While the solicitation number is not provided in the data, the official portal for submissions and further details is accessible via the DIBBS platform at the designated link. There is no set-aside classification indicated, meaning the contract is open to all eligible subcontractors regardless of business size or status, and no point of contact information is listed, suggesting all communications should be handled through the DIBBS system. Compliance with all military labeling, packaging, and hazardous materials protocols is non-negotiable for award consideration.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Specialized Packaging and Barcoding for Medical DevicesThe contract requires specialized packaging and barcoding services for medical litters designed to meet military compliance standards, including adherence to MMS No. 1 and MIL-STD-129 requirements. All packaging must incorporate GS1-compliant barcodes and human-readable data to ensure accurate identification, tracking, and logistics handling throughout the defense supply chain. The work must align with federal specifications for medical device packaging, ensuring durability, clarity, and regulatory conformity under extreme operational conditions. Performance is scheduled to take place in Jacksonville, with a zip code of 28545-6070, and the solicitation falls under NAICS code 325991 for other pharmaceutical and medicine manufacturing. This is a subcontract opportunity issued by the Department of Defense under the MEDICAL SUPPLY CHAIN MD SURG FSF, with a response deadline of August 10, 2026. Interested parties must submit proposals by the specified deadline to participate in the procurement process, which emphasizes stringent quality and compliance controls. The contract does not specify a set-aside category, and no point of contact information is provided in the solicitation details. Bidders are expected to demonstrate proven experience in military-grade packaging, barcoding systems, and medical device logistics, with the ability to meet exacting standards for labeling and documentation fidelity.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical-Grade Packaging and LabelingThe contract requires the provision of compliant packaging and labeling for 20-liter medical reagent units, adhering strictly to MMS1C and DLA standards. Each unit must be properly marked with a 2D Data Matrix barcode and include all mandated date and lot information to ensure traceability and regulatory compliance. The work is classified as a subcontract under NAICS code 325991, and performance is to be carried out at FPO with a ZIP code of 96694. The solicitation was posted on August 2, 2026, with a response deadline of August 10, 2026, and is managed by the Department of Defense through the Medical Supply Chain MD Surg FSF office. All deliverables must meet federal medical supply requirements without exception.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Packaging and Labeling ServicesThe contract seeks specialized packaging, labeling, and palletization services for medical supplies adhering strictly to Department of Defense standards including MIL-STD-129, RP001, and ASTM D3951, ensuring all items meet the rigorous requirements for military logistics and distribution. Services must be performed to maintain compliance with DLA specifications, covering everything from durable outer packaging and barcoded labeling to standardized pallet configurations that support efficient handling and inventory tracking within the military supply chain. This subcontract is issued by the Department of Defense under the Medical Supply Chain Pharm FSA, with performance required at the Morrisville, North Carolina location, identified by zip code 27560-0000. The solicitation was posted on August 2, 2026, with responses due by August 10, 2026, and falls under NAICS code 325991 for other chemical product and preparation manufacturing. The contract focuses on precision and regulatory adherence, emphasizing consistency, traceability, and readiness for immediate deployment in military healthcare environments.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ComplianceThe contract requires compliance with MIL-STD-129 standards for the packaging and labeling of pharmaceutical shipments, ensuring all items are properly marked with required military identifiers including NSN, TCN, and CAGE codes. Traceable barcodes must be applied in accordance with federal and defense logistics specifications to enable accurate tracking and inventory management throughout the supply chain. The work is performed under a subcontract to support the Defense Logistics Agency, with the North American Industry Classification System code 325991 indicating specialized pharmaceutical manufacturing activities. All packaging and labeling activities must meet exacting defense transportation and storage requirements, designed to ensure uniformity, durability, and readability under operational conditions. The contract is tied to the procurement vehicle SPE2DX25D8022 and delivery order SPE2D926F7855, and performance is governed by the strict adherence to Department of Defense logistics protocols, though the specific location of performance is not detailed. The solicitation was posted in August 2026 and does not specify a set-aside classification, indicating it is open to general subcontractors capable of meeting the technical and regulatory demands of military pharmaceutical logistics.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThe contract requires the packaging, labeling, and kitting of Amoxicillin tablets to comply with stringent military standards including DLA specifications, MIL-STD-2073-1E, and hazardous material labeling requirements. All work must be performed to ensure the integrity, safety, and regulatory compliance of pharmaceutical products intended for military use, with particular attention to handling, containment, and documentation of controlled substances. The performance location is specified as Fort Lewis, Washington, with a zip code of 98433-9500, and the North American Industry Classification System code is 325991, indicating specialized pharmaceutical manufacturing services. The opportunity is classified as a subcontract under the Department of Defense's Medical Supply Chain Pharm FSA, with a response deadline of August 10, 2026, and a posted date of August 2, 2026. There is no solicitation number provided and no set-aside designation, meaning the contract is open to eligible subcontractors without restrictions based on small business status or other categories. All participants must meet all federal and military regulatory requirements for handling pharmaceuticals and hazardous materials, and any failure to adhere to labeling or packaging protocols may result in rejection of deliverables. The official reference for additional information is available through the DIBBS platform at the provided UI link.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Nonmetallic Seal Manufacturing and SupplyThe contract is for the manufacture and supply of nonmetallic round section seals, including O-rings and gaskets, that meet military specifications and packaging standards under an IDIQ framework. These seals are critical components used in defense applications where reliability and adherence to strict performance criteria are mandatory. The solicitation is structured as a subcontract and is set aside exclusively for Women-Owned Small Businesses, aligning with the WOSB set-aside program to promote diversity and inclusion in defense contracting. The NAICS code 325991 designates the industry as other chemical product and preparation manufacturing, which encompasses the production of specialized elastomeric and nonmetallic sealing products. The procurement is managed by the Land Supply Chain under the Department of Defense and is open for responses through August 17, 2026, with the solicitation posted on August 2, 2026. Performance will be carried out in accordance with federal defense logistics requirements, and all delivered items must comply with specified military standards for material composition, dimensional tolerances, environmental resistance, and packaging to ensure compatibility with existing military systems and supply chains.

LAND SUPPLY CHAIN

POSTED

DEADLINE

Medical Packaging and Labeling ServicesThe contract seeks qualified subcontractors to provide comprehensive packaging, labeling, and kitting services for medical items according to strict Department of Defense specifications. Services must include accurate expiration dating, detailed lot tracking, and NSN barcoding to ensure full traceability and compliance with military supply chain standards. All work must be performed to meet the rigorous quality and documentation requirements governing medical supplies distributed to U.S. military personnel. The place of performance is designated as APO 09094-3219, and the contract falls under NAICS code 325991 for other pharmaceutical and medicine manufacturing. The solicitation was posted on August 2, 2026, with a firm response deadline of August 10, 2026. While the contract is classified as a subcontract, no set-aside provisions apply, and the agency responsible is the Medical Supply Chain MD Surg FSF under the Department of Defense. Prospective bidders must be prepared to adhere to all federal and DOD regulatory guidelines for medical device handling, labeling, and logistics.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

GABAPENTIN CAPSULES

Solicitation # SPE2DP-26-T-4457

GABAPENTIN CAPSULES, 100 MG in units of 100s, are procured under solicitation SPE2DP-26-T-4457 with a total requirement of 7,000 capsules across two line items, each with a 0% quantity variance. The item is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, including shelf-life specifications of 36 months non-extendable for TYPE I (CODE Q) items. Packaging must meet Commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with all labeling and palletization aligned to RP001 and DLA packaging directives. Storage must maintain 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) per USP Controlled Room Temperature. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged in accordance with ASTM D3951, though DLA requirements override any conflicting standards. Delivery is FOB destination with a five-day lead time and inspection and acceptance occurring at the destination point. The items are to be shipped via traceable means, not parcel post, to the USS MAKIN ISLAND LHD 8 at FPO AP 96672, with a required delivery date of April 3, 2026. Manufacturers include MARLEX PHARMACEUTICALS INC, CIPLA USA INC, and SCIEGEN PHARMACEUTICALS INC, identified by their respective NDC codes. The unit of issue is BT (100s), with each unit pack containing one BT. All packaging and marking must reflect the correct NSN 6505013871892, and vendors must use the DLA VSM system for shipment tracking. Government use codes and contract identifiers are specified for administrative and logistical tracking, and all documentation must adhere to the latest DLA procedural notes for transportation, marking, and delivery verification.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

TOLNAFTATE POWDER, U

Solicitation # SPE2DP-26-T-4452

The contract specifies the procurement of Tolnaftate Powder, USP 1%, in 45-gram units, with a total quantity of 19 BT (each BT equaling 45 grams), supplied by Geri-Care Pharmaceuticals Corp. under part number NDC57896-0199-45 and NSN 6505014807897. Delivery is required within five days FOB destination, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The product must comply with strict packaging and marking standards, including Medical Marking Standard No. 1, which replaces all references to MIL-STD-129, and must be packed in sealed unit containers and commercial shipping containers ensuring safe transport at the lowest carrier rate. The item is classified as a TYPE I (CODE Q) medical product with a non-extendable shelf life of 36 months. All packaging and labeling must adhere to DLA requirements outlined in the Master List of Technical and Quality Requirements, and covered defense information protocols apply. The solicitation, issued under SPE2DP-26-T-4452 with a response deadline of August 10, 2026, is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with point of contact Imerah Burnett at Offutt AFB, and the unit of issue follows DoD authorization with corresponding ANSI X12 alignment.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

LIDOCAINE HYDROCHLORID

Solicitation # SPE2DP-26-T-4454

Lidocaine hydrochloride and dextrose injection in 500 mL premixed bags, containing 0.4% lidocaine and 5% dextrose, is being procured under solicitation SPE2DP-26-T-4454 with a unit of issue defined as a package of 18 bags. The item must meet stringent technical and quality standards outlined in the DLA Master List of Technical and Quality Requirements, and packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129. At least 16 months of shelf life must remain at the time of delivery to the first government activity, as the product has a fixed 18-month non-extendable shelf life under Type I (Code K) requirements. The drug is regulated by the FDA, and contractors must ensure full compliance with all applicable federal standards for commercial packaging, including ASTM D3951 where applicable, though DLA requirements take precedence. The product is currently in limited supply due to manufacturing constraints, and only Baxter Healthcare Corp’s specific NDC 00338-0409-03 and part number 2B0973P are authorized. Delivery is required within five days of award, FOB destination, with zero variance permitted in quantity. The shipment must be sent via traceable and expedited means to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632, using RDD 777 and VSM logistics protocols, and parcel post is strictly prohibited. Packaging must be palletized according to RP001 requirements and labeled in full compliance with DLA’s medical marking standards. The contract specifies a single purchase request quantity of one package, with a required delivery date of August 5, 2026, and procurement is managed by the Department of Defense’s Medical Supply Chain PHARM FSA. All bidders must provide detailed manufacturer and product information for FDA verification through EBS referral prior to award.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

SODIUM CHLORIDE IRRIGA

Solicitation # SPE2DP-26-T-4449

Sodium Chloride Irrigation, USP, is prescribed as a 0.9% solution in 250 mL plastic squeeze bottles, packaged 24 bottles per packing group, and must be stored at controlled room temperature of 25 degrees Celsius with protection from excessive heat. The product must comply with the DLA Master List of Technical and Quality Requirements, and its shelf life is fixed at 36 months without extension, classified as a Type I (Code Q) item. All packaging and labeling must adhere strictly to Medical Marking Standard No. 1, superseding MIL-STD-129, with documentation available via DLA Troop Support. Each unit must be sealed and protected from damage, and shipped in commercial exterior containers suitable for safe delivery by common carrier at the lowest cost to the designated destination. The item is identified by NSN 6505-01-253-8150 and NDC 00338-0048-02, supplied by Baxter Healthcare Corp, and is subject to a firm fixed price with zero variance allowed in quantity. Delivery is required FOB destination within five days of contract award, with inspection and acceptance occurring at the point of delivery. The contract is issued under solicitation SPE2DP-26-T-4449, with a response deadline of August 10, 2026, and falls under NAICS code 325412 for pharmaceutical preparation manufacturing. All data, including point of contact James Foggie and delivery location at Fort Bragg, NC, is governed by Federal procurement standards under the Department of Defense.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

BISMUTH SUBSALICYLA

Solicitation # SPE2DP-26-T-4459

The contract pertains to the procurement of Bismuth Subsalicylate Suspension, 262 mg per 15 mL, in 240 mL bottles, with a total order of two bottles. The item has a non-extendable shelf life of 24 months, and no more than 85 percent of that shelf life may have elapsed between the date of manufacture and the date of delivery to the government. Packaging must comply with commercial standards and meet the requirements of Medical Marking Standard No. 1, which supersedes MIL-STD-129; each unit must be sealed in a container that protects against damage, and all shipping containers must ensure safe, cost-effective delivery via common carrier to the designated destination. The product is regulated by the FDA and requires referral through EBS for confirmation by a product specialist, including full manufacturer and bidder details. Labeling, marking, and packaging must adhere strictly to the latest edition of Medical Marking Standard No. 1, accessible via the DLA website. Delivery is FOB destination within 20 days of contract award, with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The item is identified by NSN 6505015056483, NDC 00536-1286-36, and is sourced from The Harvard Drug Group, L.L.C. under solicitation SPE2DP-26-T-4459, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with performance at Fort Drum, NY.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

ARTIFICIAL TEARS SOLUT

Solicitation # SPE2DP-26-T-4455

The contract specifies the procurement of 20 packages of Artificial Tears Solution, each package containing 30 single-dose vials of 0.3 mL, for a total of 600 vials. The item is regulated by the FDA and has a non-extendable shelf life of 24 months, adhering to RS001 for TYPE I (CODE M) items. Packaging must comply with the Medical Marking Standard No. 1, superseding MIL-STD-129, and all units must be hermetically sealed and protected against damage, packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost. The product, manufactured by Allergan Inc with NDC 00023-4554-30, must be labeled and marked per DLA specifications and is not considered hazardous under Fed-Std-313, requiring commercial packaging consistent with ASTM D3951 unless superseded by higher-priority DLA technical requirements. Delivery is FOB destination within five days of order, with zero tolerance for quantity variance, and must be shipped by traceable means—parcel post is prohibited. The shipment is destined for USS THEODORE ROOSEVELT CVN 71, FPO AP 96632, with a required delivery date of August 5, 2026, and must include all applicable DLA packaging and labeling standards including palletization per RP001. The contracting official must submit an EBS referral for FDA confirmation, including manufacturer and product details.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

LIDOCAINE HYDROCHLORID

Solicitation # SPE2DP-26-T-4451

This contract specifies the procurement of 2 units of Lidocaine Hydrochloride and Epinephrine Injection, USP, each unit containing 50 cartridges of 1.7 mL with a concentration of 2% Lidocaine Hydrochloride and a 1:100,000 ratio of Epinephrine. The product is designated for local dental anesthesia via nerve block or infiltration only, must be stored at controlled room temperature below 25°C, protected from light, and must not be permitted to freeze. The item is latex-free and regulated by the FDA. A minimum of 13 months of remaining shelf life is required upon receipt by the first government activity, with a total shelf life of 15 months that is non-extendable. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be suitable for commercial shipping with protection against damage and breakage. Packaging must conform to ASTM D3951 unless otherwise overridden by DLA’s Master List of Technical and Quality Requirements, and hazardous material protocols under FED-STD-313 must be followed if applicable. Units are packed as 50 cartridges per unit of issue (PG), and palletization must meet DLA’s procurement packaging standards. Delivery is required FOB destination within 20 days of contract award to Joint Base Charleston, SC, and must be shipped via traceable logistics—parcel post is prohibited. The contract is issued under solicitation SPE2DP-26-T-4451 with a response deadline of August 10, 2026, and the item’s NSN is 6505-01-597-1328. Approved manufacturers include Henry Schein, Inc., Benco Dental Supply Co., and Darby Dental Supply, LLC, with specific part and NDC numbers listed. All documentation and labeling must strictly adhere to DLA requirements and FDA regulations.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

MAGNESIUM SULFATE

Solicitation # SPE2DP-26-T-4456

MAGNESIUM SULFATE 495MG/5GM oral granules in 454GM bags, sold in cases of 12 bags each, is procured under contract SPE2DP-26-T-4456 for delivery to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632 with a five-day delivery window and no tolerance for quantity variance. The product is classified as a TYPE I (CODE Q) medical item with a non-extendable shelf life of 36 months and must comply with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. All packaging must meet commercial standards as specified in DLA’s procurement requirements, ensuring each unit is sealed in protective containers and packed in exterior shipping containers suitable for safe, low-cost transport by common carrier to the destination. Palletization and labeling must adhere to DLA’s Packaging Requirements for Procurement and the latest version of Medical Marking Standard No. 1, available through DLA Troop Support or their official website. The item is identified by NSN 6505-01-714-4975 and NDC 46122-0461-43, supplied by AMERISOURCEBERGEN DRUG CORP, and shipped via traceable methods only—parcel post is prohibited. Delivery is FOB destination with inspection and acceptance also occurring at the point of delivery, and the required delivery date is August 5, 2026.

Medicinal and Botanical Manufacturing

POSTED

about 11 hours ago

DEADLINE

CYCLOSPORINE OPHTHA

Solicitation # SPE2DP-26-T-4453

Cyclosporine Ophthalmic Ointment, 0.2% per gram, in a 3.5 gram sterile, preservative-free tube, is designated for veterinary use in managing keratoconjunctivitis sicca in dogs. The unit of issue is a package containing six tubes, and the product must be stored at controlled room temperature. It is subject to strict packaging standards per the latest Medical Marking Standard No. 1 and requires marking in accordance with MMS No. 1B dated 30 March 2017. The item has a non-extendable shelf life of 24 months under RS016 compliance. The product is supplied by multiple manufacturers including Merck Sharp & Dohme LLC, Patterson Veterinary Supply, Inc., and Penn Veterinary Supply Inc., each with their respective part numbers and NDC codes. This item is procured under the Department of Defense with NSN 6509-01-530-4765 and purchase request 7017723033, with a contract solicitation number SPE2DP-26-T-4453. Delivery is scheduled for 89 days after award, FOB destination, with zero variance permitted in quantity, and inspection and acceptance occur at the destination. Packaging must meet MIL-STD-2073-1E specifications, and defense information handling requirements apply. The point of contact for the solicitation is Shairy M. Cartagena at the Medical Supply Chain Pharm FSA under the DLA.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

WATER PURIFICATION TAB

Solicitation # SPE2DP-26-T-4448

The contract specifies the procurement of 200 units of water purification tablets containing stabilized chlorine dioxide, with no active chlorine or iodine, designed for military use in first aid kits. Each unit, designated as PG, contains ten individually sealed tablets and must meet a strict 60-month shelf life, with at least 51 months remaining upon delivery to the government. The product, identified by NSN 6850-01-530-3396 and part number 8014821 from KATADYN NORTH AMERICA INC., is subject to the Hazard Communication Standard as revised under OSHA’s alignment with the Globally Harmonized System, requiring suppliers to submit approved Safety Data Sheets and compliant labels prior to award, along with employee training on updated hazard communication protocols. Packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and comply with MIL-STD-2073-1E for protective sealing and shipping containers suitable for common carrier transport at the lowest cost to the destination point of APO with ZIP 96260-5479. Delivery is required within 84 days FOB destination, with zero tolerance for quantity variance, and inspection and acceptance occur at the point of delivery. The item is classified as a TYPE I (CODE S) under shelf-life requirement RS001, which prohibits extension beyond the 60-month limit. All technical and quality requirements referenced are governed by the DLA Master List, and the solicitation number SPE2DP-26-T-4448 governs procurement terms under a federal acquisition vehicle.

All Other Miscellaneous Chemical Product and Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

WATER FOR IRRIGATION, S

Solicitation # SPE2DP-26-T-4458

Water for Irrigation, Sterile, USP, is a sterile, distilled, nonpyrogenic solution intended exclusively for irrigation, washing, rinsing, and dilution purposes and is not for injection by any parenteral route. Each unit is a 1000 mL semi-rigid plastic container with a screw cap, available with or without a hanging device, and is packaged in cases of 12 units per package, the unit of issue. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat, and has a non-extendable shelf life of 36 months. It is regulated by the FDA and must be marked in compliance with the latest edition of Medical Marking Standard No. 1 and labeled according to MIL-STD-129. Packaging must adhere to DLA’s RP001 requirements and ASTM D3951 for non-hazardous materials, with DLA’s technical and quality requirements overriding any conflicting standards. The item is identified by NSN 6505-01-075-0679 and NDC 00338-0004-04, manufactured by Baxter Healthcare Corporation. The contract specifies delivery of two packages totaling 24 units, with delivery due within 20 days to two separate destinations: USS William P Lawrence DDG 110 and USS Zumwalt DDG 1000, FOB destination. Inspection and acceptance occur at the delivery point, with zero variance permitted in quantity. Shipping must use traceable transport methods, and parcel post is prohibited. All requirements, including those from the DLA Master List of Technical and Quality Requirements, must be strictly followed, and the solicitation, issued by the Department of Defense, has a response deadline of August 10, 2026, with a contract award anticipated in support of military medical supply needs.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

RINGER'S INJECTION, LAC

Solicitation # SPE2DP-26-T-4450

RINGER’S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per package, is procured under contract SPE2DP-26-T-4450 with a delivery requirement of 20 days FOB destination. The item is regulated by the FDA and requires prior confirmation by a product specialist through EBS referral, including full bidder and manufacturer details such as B. BRAUN MEDICAL INC, part number L7500, and NDC 00264-7750-00. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport via common carrier at the lowest cost. All packaging and labeling must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must be marked according to the latest edition of MMS NO. 1, accessible via DLA’s website. The product has a non-extendable shelf life of 30 months and must be stored at or near room temperature (25°C), with brief exposure to 40°C permitted without degradation. Inspection and acceptance occur at the destination, with zero tolerance for quantity variance. The unit of issue is one package (PG), equal to 12 units, and the NSN is 6505013306267. Technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date. Delivery is to Gastonia, NC, and the contracting office is under the Department of Defense’s Medical Supply Chain.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE